Vol. 27.S2 January 2022 | Annals of Hepatology

PREVALENCE AND CHARACTERISTICS OF PORTAL VEIN RECANALIZATION IN CIRRHOTIC PATIENTS ADMITTED WITH PORTAL THROMBOSIS IN A THIRD LEVEL CARE CENTER

C.A. Campoverde-Espinoza, A. Martínez-Tovar, F. Higuera de la Tijera

Ann Hepatol. 2022;27 Supl 2:100593

Open access

Share

INITIAL EVALUATION OF KIDNEY FUNCTION IN PATIENTS WITH LIVER CIRRHOSIS OF CEIHET, HIDALGO

R. Contreras-Omaña, M. Baca-García, S. Tellez-Jaen

Ann Hepatol. 2022;27 Supl 2:100594

Open access

Share

IMPACT OF REFRACTORY ASCITES ON THE SURVIVAL OF PATIENTS WITH CIRRHOSIS

P.L. Pérez-Santos, M.F. Higuera de la Tijera, D. Santana-Vargas, J.E. Lira-Vera, O. Morales-Gutiérrez, V.M. Mendoza-Martínez, J.L. Pérez-Hernández

Ann Hepatol. 2022;27 Supl 2:100595

Open access

Share

EXPERIENCE IN THE USE OF HUMAN ALBUMIN IN COMPLICATIONS OF LIVER CIRRHOSIS AT HOSPITAL JUÁREZ DE MÉXICO

R. Chicas-López, T. Deaquino Reyes, S. Mejía Loza

Ann Hepatol. 2022;27 Supl 2:100596

Open access

Share

CHANGES IN CARDIAC FUNCTION IN PATIENTS WITH DECOMPENSATED CHRONIC LIVER FAILURE

M.E. Robles-Villagómez, J.G. Gandara-Calderón, A. Gutiérrez-Atemis, C. Montejo-Velázquez, E. Cerda-Reyes

Ann Hepatol. 2022;27 Supl 2:100597

Open access

Share

EFFICACY AND SAFETY OF TERLIPRESSIN INFUSION VS BOLUS TREATMENT IN DIGESTIVE BLEEDING OF VARICEAL ORIGIN AT THE PUEBLA SPECIALTY HOSPITAL, PRELIMINARY RESULTS

N. Moreno-Aguilar, D.E. Meléndez-Mena, M.A. Mendoza-Torres

Ann Hepatol. 2022;27 Supl 2:100598

Open access

Share

DIABETES AS A CAUSE OF DECOMPENSATION IN HEPATIC CIRRHOSIS

G. Martínez Ramírez, G. Vargas Ayala

Ann Hepatol. 2022;27 Supl 2:100599

Open access

Share

COMPLICATION ASSOCIATED WITH UPPER GASTROINTESTINAL BLEEDING AMONG MEXICAN PATIENTS WITH CIRRHOSIS

F.A. Lajud-Barquin, M.F. Higuera de la Tijera, J.L. Pérez-Hernández, I.E. Bravo-Espinoza, R.Y. López-Pérez, M.O. Santana-Montes, P.M. Diego-Salazar

Ann Hepatol. 2022;27 Supl 2:100600

Open access

Share

TRENDS OF CHRONIC LIVER DISEASES IN THE UNIVERSITY HOSPITAL, UANL FOR 25 YEARS. A SINGLE-CENTER EXPERIENCE

L.E. Munoz-Espinosa, C. Trevino-Garcia, I.G. Lopez-Reyna, A. Regalado-Ceballos, P. Cordero-Perez, Y.G. Alonso-Cruz, V.H. Avalos-Gómez, R. Martinez-Macias, ... I.E. Hernandez-Padilla

Ann Hepatol. 2022;27 Supl 2:100601

Open access

Share

CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTS

A.B. Moreno-Cobos, J.L. Pérez-Hernández, B.A. Enríquez-Constantino, M.Y Carmona-Castillo, E.J. Medina-Ávalos, C.L. Dorantes-Nava, M.F. Higuera-De la Tijera

Ann Hepatol. 2022;27 Supl 2:100602

Open access

Share

PREVALENCE AND CLINICAL CHARACTERISTICS OF FATTY HEPATIC DISEASE ASSOCIATED WITH METABOLIC DYSFUNCTION IN A POPULATION WITH NORMAL BODY MASS INDEX. (LEAN MAFLD)

A.L. Ordóñez-Vázquez, D. Pérez, J.P. Soriano, E. Tovar, E. Juárez, M. Uribe, Y.I. López

Ann Hepatol. 2022;27 Supl 2:100603

Open access

Share

INCIDENTAL FINDING OF FATTY LIVER IN AUTOPSIES

I.E. Bravo-Espinoza, G. Arist-Urista, M.A. Durán-Padilla, J.L. Pérez-Hernández, R.Y. López-Pérez, P.L. Pérez-Santos, J.L. Montenegro-Tablada, J. Escobedo-Uribe, ... F. Higuera-De la Tijera

Ann Hepatol. 2022;27 Supl 2:100604

Open access

Share

FREQUENCY OF RISK FACTORS FOR DEVELOPMENT OF METABOLIC FATTY LIVER DISEASE (MAFLD) IN A CENTER OF CONCENTRATION OF LIVER DISEASES

S. Tellez-Jaen, G. López-Rodríguez, R. Contreras-Omaña, M.A González-Unzaga

Ann Hepatol. 2022;27 Supl 2:100605

Open access

Share

PREVALENCE OF COMBINED LIVER DAMAGE IN MEXICAN POPULATION

J.E. Lira-Vera, O. Morales-Gutiérrez, F.Y. Vargas-Durán, P. Alagón-Fernández del Campo, A.K. Soto-Martínez, G. Gutiérrez-Reyes, M. Martínez-Castillo, A.S. Sánchez-Valle, ... J.L. Pérez-Hernández

Ann Hepatol. 2022;27 Supl 2:100606

Open access

Share

HEPATOCELLULAR CARCINOMA AFTER DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C IN PATIENTS WITH DECOMPENSATED CIRRHOSIS

F- Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, ... E. Rodríguez-Fuentes

Ann Hepatol. 2022;27 Supl 2:100607

Open access

Share

HEPATOCELLULAR CARCINOMA IN VERACRUZ: A SURVEILLANCE COMPARISON BETWEEN TREATMENTS

G.A. Salgado-Álvarez, A.D. Cano-Contreras, G. Martínez-Mier, M.J.J. García-Carvajal, P. Grube-Pagola, I. Morales-García, J.M. Remes-Troche

Ann Hepatol. 2022;27 Supl 2:100608

Open access

Share

HEPATOCELLULAR CARCINOMA: CLINICAL AND EPIDEMIOLOGICAL FEATURES IN VERACRUZ

M.J.J. García-Carvajal, A.D. Cano-Contreras, G. Martínez-Mier, G.A. Salgado-Álvarez, I. Morales García, P. Grube-P, J.M. Remes-Troche

Ann Hepatol. 2022;27 Supl 2:100609

Open access

Share

A MULTICENTER REAL-WORLD COHORT TO VALIDATE THE EFFICACY AND SAFETY OF DIRECT ANTIVIRAL AGENTS FOR HEPATITIS C, AND RELATED RISK FACTORS FOR NON-SVR IN DECOMPENSATED CIRRHOSIS

F. Higuera-de-la-Tijera, N.C. Flores-García, D. Kershenobich, E. Cerda-Reyes, M.S. González-Huezo, J.L. Pérez-Hernández, N. Méndez-Sánchez, O. Morales-Gutiérrez, ... E. Rodríguez-Fuentes

Ann Hepatol. 2022;27 Supl 2:100610

Open access

Share

STUDY OF CONCORDANCE BETWEEN THE DEGREE OF LIVER FIBROSIS ESTIMATED THROUGH APRI AND FIB-4 BIOCHEMICAL SCORES, AND ELASTORESONANCE IN PATIENTS WITH AUTOIMMUNE HEPATITIS

P.D. Flores Rangel, N.A. Bolaños Gómez, L.A. Murrieta González, A.B. Craviotto Rivera, E. Cerda Reyes

Ann Hepatol. 2022;27 Supl 2:100611

Open access

Share

GLUCOGENOSIS AS A CAUSE OF INTRAHEPATIC CHOLESTASIS

K.Y. Santoyo López, A Domínguez García

Ann Hepatol. 2022;27 Supl 2:100612

Open access

Share

ADDRESSING THE INFILTRATIVE PATTERN: COMPLEX DIAGNOSIS

A.L. Ordóñez-Vázquez, J. Prieto-Nava, F. Ayala-Ochoa, A. Heredia-Jara, L. Montiel-Velázquez, I. López-Méndez

Ann Hepatol. 2022;27 Supl 2:100613

Open access

Share

PRIMARY BILIARY CHOLANGITIS COMPLICATED WITH ULCERATIVE COLITIS: A CASE REPORT

J.C. Valles Gonzales, O. García Rodas, N. Pérez y López, C.A. Hernández Cuevas

Ann Hepatol. 2022;27 Supl 2:100614

Open access

Share

AUTO IMMUNE HEPATITIS AS A LIVER MANIFESTATION OF COMMON VARIABLE IMMUNODEFICIENCY: A CASE REPORT

O.L. García Rodas, F. Sánchez Salinas, S.M.I. Mejía Loza

Ann Hepatol. 2022;27 Supl 2:100615

Open access

Share

PORTA VEIN THROMBOSIS (PVT) IN CIRRHOTIC PATIENTS PRE AND DURING THE PANDEMIC BY SARS-COV2

C.A. Campoverde-Espinoza, A. Martínez-Tovar, M.F. Higuera de la Tijera

Ann Hepatol. 2022;27 Supl 2:100616

Open access

Share

HEPATIC FUNCTION ALTERATIONS IN SARS-COV 2 HOSPITALIZED PATIENTS AT HOSPITAL 450, DURANGO

J.S. Jacobo Karam, M.A. Vazquez-Garcia, C.G. Lerma-Burciaga, M.E. Rábago-Sánchez, G. Valencia-Pérez, H.A. Almonte de León, A.G. Calvillo-Carrillo, L.E. Zavala-Fernández, O. López-Gómez

Ann Hepatol. 2022;27 Supl 2:100617

Open access

Share

FREQUENCY OF HEPATIC FUNCTION ALTERATION IN MEXICAN PATIENTS WITH COVID-19 AND ITS ASSOCIATION WITH THE SEVERITY OF ACUTE RESPIRATORY DISTRESS SYNDROME: PRELIMINARY RESULTS

A.B. Vera-Heredia, M.I. Mejía-Loza, E.C. Macías-Cortés

Ann Hepatol. 2022;27 Supl 2:100618

Open access

Share

RELIABILITY FACTORS FOR THE MEASUREMENT OF HEPATIC STEATOSIS BY MEANS OF A CONTROLLED ATTENUATION PARAMETER BY TRANSIENT ELASTOGRAPHY

M. Figueroa Palafox, E. Juárez-Hernández, Y.I. Lopez-Mendéz

Ann Hepatol. 2022;27 Supl 2:100619

Open access

Share

COMPARISON OF SEROLOGICAL MODELS OF LIVER FIBROSIS AGAINST TRANSIENT ELASTOGRAPHY BY FIBROSCAN® IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE

J. Aquino-Matus, J. Jiménez-Pavón, M. Uribe, N. Chavez-Tapia

Ann Hepatol. 2022;27 Supl 2:100620

Open access

Share

NEOBUXBAMIA TETETZO AS A CAUSE OF DRUG-INDUCED LIVER INJURY

A.C. Chavarín Meza, C. Diéguez-Campa, O. León-Mondragón, L. Juarez-Chavez

Ann Hepatol. 2022;27 Supl 2:100621

Open access

Share

HEPATIC MANIFESTATIONS OF INFECTIOUS DISEASES. PRESENTATION OF CLINICAL CASE

S.L. Falcón González, B.M. Morales Matamoros, K.G. Córdova García, F.A. Reynoso Zarzosa

Ann Hepatol. 2022;27 Supl 2:100622

Open access

Share

HEPATIC STEATOSIS IN CYSTIC FIBROSIS. APROPOS OF A CASE

S.L. Falcón González, M. Lescas Orozco, Y.S. Sosa Pech, F.A. Reynoso Zarzosa

Ann Hepatol. 2022;27 Supl 2:100623

Open access

Share

NEUTROPHILE/LYMPHOCYTE INDEX (IN/L), CREATININE (Cr), AND PROCALCITONIN (PROCAL) AS PREDICTORS OF AMEBIAN LIVER ABSCESS.

C.A. Campoverde-Espinoza, A. Martínez-Tovar, F. Higuera de la Tijera

Ann Hepatol. 2022;27 Supl 2:100624

Open access

Share

CLINICAL, BIOCHEMICAL, AND IMAGE CHARACTERISTICS IN PATIENTS WITH A DIAGNOSIS OF AMEBIC AND BACTERIAL LIVER ABSCESS.

C.A. Campoverde-Espinoza, A. Martínez-Tovar, F. Higuera de la Tijera

Ann Hepatol. 2022;27 Supl 2:100625

Open access

Share

IMPACT OF RISK FACTORS IN THE SCRUTINY AND DIAGNOSIS OF HEPATITIS C

J. Méndez-Navarro, R.A. Chirino-Sprung, A. Azamar-Alonso, D. Kershenobich

Ann Hepatol. 2022;27 Supl 2:100626

Open access

Share

CLEAR CELL HEPATOCELLULAR CARCINOMA, A CASE REPORT

M. Velasco-Gutiérrez, K.M. Ortiz-Aguirre, F.I. Garcia-Juarez, E.M. Zamayoa-Cervantes

Ann Hepatol. 2022;27 Supl 2:100627

Open access

Share

FRUCTOSE DIET INDUCES A METABOLIC REPROGRAMMING TO ENHANCE TUMOR AGGRESSIVENESS

L. Chávez-Rodríguez, A. Escobedo-Calvario, A. Simoni-Nieves, L. Bucio, V. Souza, R.U. Miranda Labra, G.C. Enriquez-Cortina, F. Masso, ... L.E. Gómez-Quiroz

Ann Hepatol. 2022;27 Supl 2:100628

Open access

Share

ANTIOXIDANT EFFECT OF SPINACH EXTRACT IN LIVER FIBROGENESIS ASSOCIATED TO ACTIVATION OF NRF2/HO-1 IN HYPERGLYCEMIC RATS

J.J. Flores Estrada, A. Cano Martínez, S.M.I. Mejía Loza, A. Vargas González, Z.J. Rodríguez Serrano, R.M. Pérez Gutiérrez, O.L. García Rodas

Ann Hepatol. 2022;27 Supl 2:100629

Open access

Share

NAMPT INHIBITION AND INCREASED NAD-BIOAVAILABILITY ATENUATE LIVER DAMAGE IN CCl4-INDUCED MICE CHRONIC LIVER DISEASE

J.A. Gutiérrez buendía, R. Pérez Cabeza de Vaca, G.A. Domínguez Pérez, E. Vera Gomez, A. Hernández Patricio, K. Moreno Vega, M. Salamanca García, J.I. Bustamante Santillan, ... J.A. Suárez Cuenca

Ann Hepatol. 2022;27 Supl 2:100630

Open access

Share

“THE EFFECT OF GROWTH DIFFERENTIATION FACTOR 11 (GDF11) ON THE RESPONSE OF TUMOR-ASSOCIATED MACROPHAGES IN HEPATOCELLULAR CARCINOMA DERIVED CELLS”

A. Escobedo-Calvario, L. Chávez-Rodríguez, V. Souza, R.U. Miranda Labra, F. Masso, A. Páez-Arenas, R. Hernández-Pando, L.E. Gómez-Quiroz, María C. Gutiérrez-Ruíz

Ann Hepatol. 2022;27 Supl 2:100631

Open access

Share

EFFECT OF SUPPLEMENTATION WITH TYPICAL MEXICAN FOODS (OPTUNA FICUS INDICA, THEOBROMA CACAO AND EDIBLE CRICKETS) IN HIGH-FAT/HIGH-SUGAR DIET-FED MICE

R. Rosas Campos, A. Meza Ríos, S. Rodríguez Sanabria, R. de la Rosa Bibiano, A. Sandoval Rodríguez, J. Armendáriz Borunda

Ann Hepatol. 2022;27 Supl 2:100632

Open access

Share

EVALUATION OF THE HEPATOPROTECTOR EFFECT OF A SUPPLEMENT WITH CURCUMA LONGA AGAINST REPERFUSION ISCHEMIA DAMAGE IN AN EXPERIMENTAL MODEL IN WISTAR RATS

P. Cordero- Pérez, AG Flores de Alejandro, L.E. Muñoz-Espinosa, L. Torres-González, D.P. Moreno Peña, D.R. Rodríguez-Rodríguez, E. Pérez-Rodriguez

Ann Hepatol. 2022;27 Supl 2:100633

Open access

Share

CHEMOSENSITIZING EFFECTS OF GDF11 IN HUMAN HEPATOCELLULAR CARCINOMA CELLS

N. German-Ramirez, G.I. Domínguez-Gómez, A. Simoni-Nieves, M. Gerardo-Ramírez, L. Bucio-Ortiz, María C. Gutiérrez-Ruiz, Luis E. Gómez-Quiroz

Ann Hepatol. 2022;27 Supl 2:100634

Open access

Share

HGF AND PROTECTIVE ROLL IN THE INTESTINAL COLLATERAL DAMAGE BY Α-NAFTILISOTIOCIANATO- INDUCE CHOLESTASIS.

J. Lopez-Ramirez, M. García-Barrera, N. Nuño-Lámbarri, S. Salas-Silva, M.C. Gutiérrez-Ruiz, V. Souza, L.E. Gomez-Quiroz, L. Bucio Ortiz

Ann Hepatol. 2022;27 Supl 2:100635

Open access

Share

IGFBP-1 TO 7 AS BIOMARKERS IN STAGES OF LIVER FIBROSIS DURING VIRAL HEPATITIS C

M. Martínez-Castillo, D. Santana-Vargas, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Kershenobich, G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100636

Open access

Share

LYMPHOCYTE PROFILE ON PATIENTS WITH CHRONIC AND ACUTE ALCOHOL CONSUMPTION

Z. Medina-Avila, M. Martínez-Castillo, D. Santana-Vargas, Y. Bejar, F. Higuera de la Tijera, J.L. Pérez-Hernández, D. Kershenobich, G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100637

Open access

Share

IL-10 Y TNF-α IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS C AND HEPATIC DAMAGE CHRONIC AND ACUTE FOR ALCOHOL CONSUMPTION

M. Hernandez-Santillan, M. Martínez-Castillo, D. Santana-Vargas, Z. Medina-Avila, A. Hernández-Barragan, J. Limón-Castillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, ... G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100638

Open access

Share

DETERMINATION OF LEUKOCYTE PROFILE IN CHRONIC ALCOHOL CONSUMPTION

E.A. Alamo-Capula, M. Hernandez Santillan, A. Hernandez-Barragan, S. Sánchez-Valle, I. Altamirano-Mendoza, Z. Medina-Avila, M. Martínez-Castillo, D. Santana-Vargas, ... G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100639

Open access

Share

SERUM DETERMINATION OF MMP-2 AND MMP-9 ACCORDING TO THE PATTERN OF ALCOHOL CONSUMPTION AND IN ALCOHOLIC HEPATIC DISEASE

A. Hernandez-Barragan, M. Martinez-Castillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Santana-Vargas, D. Kershenobich, G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100640

Open access

Share

COMPARISON OF CXCL-8 and IFN-γ PRODUCTION IN ACUTE AND CHRONIC STAGES OF LIVER DISEASE

I. Altamirano-Mendoza, M. Martínez-Castillo, Z. Medina-Avila, L. García-Islas, J.L. Pérez-Hernández, F. Higuera-De la Tijera, D. Santana-Vargas, J. Cordova-Gallardo, ... G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100641

Open access

Share

OXIDATIVE DAMAGE MARKERS IN ALCOHOLIC HEPATITIS

S. Sánchez-Valle, M. Martínez-Castillo, Z. Medina-Avila, J. Castillo-Limón, L. García-Islas, M. Hernández-Santillan, A. Hernández-Barragán, D. Santana-Vargas, ... G. Gutiérrez-Reyes

Ann Hepatol. 2022;27 Supl 2:100642

Open access

Share

TOTAL CHOLESTEROL / HIGH DENSITY LIPOPROTEIN CHOLESTEROL RATIO, TRIGLYCERIDES / HIGH DENSITY LIPOPROTEIN CHOLESTEROL WITH THE CONTROLLED ATTENUATION PARAMETER (CAP) IN NON-ALCOHOLIC FATTY LIVER

C.N. Ascencio Barrientos, L.C. Barrios Lupitou, R.M. Rivera Orellana, A.G. Rivera Flores, M.I.S. Mejía Loza

Ann Hepatol. 2022;27 Supl 2:100643

Open access

Share

DIFFERENTIAL PROFILE OF PRO-INFLAMMATSORY / ANTI-INFLAMMATORY CYTOKINES AND MALONDIALDEHYDE IN PATIENTS WITH ALCOtHOL-INDUCED OR OBESITY OR MIXED INJURY

L. Torres-González, L.R. Aguilar Rivera, D.P. Moreno-Peña, O.H. Mendoza Hernández, A.A. Lugo Rodriguez, M.E. Posada Lerma, L.E. Muñoz Espinosa, H. Nañez Terreros, P. Cordero-Pérez

Ann Hepatol. 2022;27 Supl 2:100644

Open access

Share

PROFILE OF PRO AND ANTI-INFLAMMATORY CYTOKINES IN PATIENTS WITH CHRONIC LIVER DISEASE IN THE COMPENSATION, INFLAMMATION AND IMMUNOSUPPRESSION PHASES

B. Tijerina-Soto, P. Cordero-Pérez, D.P. Moreno-Peña, C. Treviño-García, L.E. Muñoz-Espinosa

Ann Hepatol. 2022;27 Supl 2:100645

Open access

Share

CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A PROMOTER IN THE DEVELOPMENT OF FIBROSIS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

E. Morales, C. Guzmán-Arriaga, M.A. Díaz-Castro, F. Higuera-de-la-Tijera, D. Santana-Vargas, E. Bautista Ubaldo, J.E. Lira-Vera, O. Morales-Gutiérrez, J.L. Pérez-Hernández

Ann Hepatol. 2022;27 Supl 2:100646

Open access

Share

Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness

L. Barrett, S. Rosati, M. Garcia-Retortillo, H. Wedemeyer, E. Teti, FA Pérez Hernández, M. Selfridge, A. Wong, ... V. Calvaruso

Ann Hepatol. 2022;27 Supl 2:100647

Open access

Share